Amgen

+$2.28 (+0.94%) Today
-$0.70 (-0.29%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Amgen and other ETFs, options, and stocks.

About AMGN

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, Aimovig, KANJINTI, EVENITY, AMGEVITA, AVSOLA, BLINCYTO, MVASI, Corlanor, Enbrel, EPOGEN, IMLYGIC, Kyprolis, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, Otezla, RIABNI, and XGEVA.

CEO
Robert A. Bradway
Employees
24,200
Headquarters
Thousand Oaks, California
Founded
1980

AMGN Key Statistics

Market cap
131.08B
Price-Earnings ratio
24.17
Dividend yield
3.02
Average volume
4.65M
High today
$246.00
Low today
$242.88
Open price
$244.29
Volume
4.53M
52 Week high
$258.45
52 Week low
$198.64

AMGN News

BenzingaJun 24

$100 Invested In Amgen 15 Years Ago Would Be Worth This Much Today

Amgen AMGN has outperformed the market over the past 15 years by 3.97% on an annualized basis producing an average annual return of 10.41%. Currently, Amgen has
Simply Wall StJun 23

Investors in Amgen have made a decent return of 60% over the past five years - Simply Wall St

If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see the share price rise faster than the mark

AMGN Earnings

$0.00
$1.56
$3.11
$4.67
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 2, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure